A new study done by scientists in Switzerland and Sweden investigated the use of automated systems to develop multispecific antibodies.

Targeting clonal antigens and circumventing dysfunctional states may be important for conferring clinical responses to TIL therapy.

Chimeric antigen receptor T-cell (CAR-T) therapies are standard of care for the treatment of several hematologic malignancies. Although patients receiving CAR-T therapies are frequently hospitalized ...

Antigenic variation: Decoding the mechanism controlling antigen activation in trypanosomes Date: March 15, 2025 Source: Ludwig-Maximilians-Universität München Summary: A new study shows how ...

Immunizations containing 1 µg of recombinant protein were performed with a volume of 50 µl (25 μl of antigen in PBS +C25 μl of AF03 per dose) 33. ELISA Anti-tetNA IgG levels in mouse sera were ...

Merck & Co. has penned a $300 million biobucks-per-product deal to identify previously secret antigens for off-the-shelf cancer immunotherapies.

Rapid Bispecific Discovery and the B-Body Bispecific Platform de-risk and accelerate antibody therapeutics.

Instant Pots are an inexpensive and readily available substitute for commercially available heat-mediated antigen retrieval equipment.